Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Novel treatment of intracerebral hemorrhage with mechanical tissue resuscitation

View through CrossRef
OBJECTIVE The previous laboratory and clinical experience of the authors had demonstrated that application of controlled subatmospheric pressure directly to injured soft tissue can result in increased survival of compromised tissues. Mechanical tissue resuscitation (MTR) is a new concept evolving from these discoveries. The authors’ recent studies have demonstrated that traumatic brain injury tissue can also be salvaged. The aim of this study was to examine the effects of MTR application to injuries from intracerebral hemorrhages (ICHs) in a swine model. METHODS The ICHs in swine were simulated by infusion of autologous artery blood into the right frontal lobe. A specially designed silicone manifold device was introduced directly into the hematoma. Continuous negative pressure at −50 mm Hg was applied through this device. T2- and T2*-weighted MRI, histological H&E staining, and immunostaining were examined. RESULTS After 1 week of treatment, MTR significantly decreased gross hematoma volume by more than 60%, from 472.62 ± 230.19 mm3 in the nontreated group to 171.25 ± 75.38 mm3 in the MTR-treated group (p < 0.05). Total hypointense volumes measured on T2*-weighted MR images decreased from 791.99 ± 360.47 mm3 in the nontreated group to 371.16 ± 105.75 mm3 in the MTR-treated group (p < 0.05). The hyperintense area on the T2-weighted MR image decreased significantly from 2656.23 ± 426.26 mm3 in the nontreated group to 1816.66 ± 525.26 mm3 in the MTR-treated group (p < 0.05). When ICHs were treated with MTR for 2 weeks, the gross hematomas were reduced by 94%, from 112.23 ± 66.21 mm3 in the nontreated group to 6.12 ± 10.99 mm3 in the MTR-treated group (p = 0.003). MTR significantly decreased the total necrotic tissue volume in H&E staining from 120.42 ± 48.35 mm3 in the nontreated group to 60.94 ± 38.99 mm3 in the MTR-treated group (p < 0.05). The total hypointense volumes on T2*-weighted MR images were significantly reduced, from 385.54 ± 93.85 mm3 in the nontreated group to 220.54 ± 104.28 mm3 in the MTR-treated group (p < 0.05), while their mean T2 hyperintense volume decreased significantly from 2192.83 ± 728.27 mm3 in the nontreated group to 1366.97 ± 463.36 mm3 in the MTR-treated group (p < 0.05). Histology revealed that the capillary diameter in the reactive tissue rim adjacent to the hematoma increased in both the 1- and 2-week MTR-treated groups. Both von Willebrand factor and CD31 signals were detectable in endothelial cells within the hematoma cavity of both MTR-treated groups. CONCLUSIONS This study demonstrates that local continuous application of controlled subatmospheric pressure to an ICH can safely remove more than half of a clot in 1 week and more than 90% in 2 weeks.
Title: Novel treatment of intracerebral hemorrhage with mechanical tissue resuscitation
Description:
OBJECTIVE The previous laboratory and clinical experience of the authors had demonstrated that application of controlled subatmospheric pressure directly to injured soft tissue can result in increased survival of compromised tissues.
Mechanical tissue resuscitation (MTR) is a new concept evolving from these discoveries.
The authors’ recent studies have demonstrated that traumatic brain injury tissue can also be salvaged.
The aim of this study was to examine the effects of MTR application to injuries from intracerebral hemorrhages (ICHs) in a swine model.
METHODS The ICHs in swine were simulated by infusion of autologous artery blood into the right frontal lobe.
A specially designed silicone manifold device was introduced directly into the hematoma.
Continuous negative pressure at −50 mm Hg was applied through this device.
T2- and T2*-weighted MRI, histological H&E staining, and immunostaining were examined.
RESULTS After 1 week of treatment, MTR significantly decreased gross hematoma volume by more than 60%, from 472.
62 ± 230.
19 mm3 in the nontreated group to 171.
25 ± 75.
38 mm3 in the MTR-treated group (p < 0.
05).
Total hypointense volumes measured on T2*-weighted MR images decreased from 791.
99 ± 360.
47 mm3 in the nontreated group to 371.
16 ± 105.
75 mm3 in the MTR-treated group (p < 0.
05).
The hyperintense area on the T2-weighted MR image decreased significantly from 2656.
23 ± 426.
26 mm3 in the nontreated group to 1816.
66 ± 525.
26 mm3 in the MTR-treated group (p < 0.
05).
When ICHs were treated with MTR for 2 weeks, the gross hematomas were reduced by 94%, from 112.
23 ± 66.
21 mm3 in the nontreated group to 6.
12 ± 10.
99 mm3 in the MTR-treated group (p = 0.
003).
MTR significantly decreased the total necrotic tissue volume in H&E staining from 120.
42 ± 48.
35 mm3 in the nontreated group to 60.
94 ± 38.
99 mm3 in the MTR-treated group (p < 0.
05).
The total hypointense volumes on T2*-weighted MR images were significantly reduced, from 385.
54 ± 93.
85 mm3 in the nontreated group to 220.
54 ± 104.
28 mm3 in the MTR-treated group (p < 0.
05), while their mean T2 hyperintense volume decreased significantly from 2192.
83 ± 728.
27 mm3 in the nontreated group to 1366.
97 ± 463.
36 mm3 in the MTR-treated group (p < 0.
05).
Histology revealed that the capillary diameter in the reactive tissue rim adjacent to the hematoma increased in both the 1- and 2-week MTR-treated groups.
Both von Willebrand factor and CD31 signals were detectable in endothelial cells within the hematoma cavity of both MTR-treated groups.
CONCLUSIONS This study demonstrates that local continuous application of controlled subatmospheric pressure to an ICH can safely remove more than half of a clot in 1 week and more than 90% in 2 weeks.

Related Results

Intracerebral Hemorrhage
Intracerebral Hemorrhage
Intracerebral hemorrhage can be classified as either secondary (due to trauma, vascular malformations, aneurysms, tumors, or hemorrhagic transformation of ischemic stroke) or prima...
Intracerebral Hemorrhage
Intracerebral Hemorrhage
Intracerebral hemorrhage can be classified as either secondary (due to trauma, vascular malformations, aneurysms, tumors, or hemorrhagic transformation of ischemic stroke) or prima...
Nationwide Big Data Analysis of Statin Use and Intracerebral Hemorrhage Risk in Acute Ischemic Stroke Patients in Taiwan
Nationwide Big Data Analysis of Statin Use and Intracerebral Hemorrhage Risk in Acute Ischemic Stroke Patients in Taiwan
Background and Objectives: Although statins are recommended for secondary prevention of acute ischemic stroke, some population-based studies and clinical evidence suggest that they...
Nontraumatic Spontaneous Bilateral Intracerebral Hemorrhage: A Rare Case Serial
Nontraumatic Spontaneous Bilateral Intracerebral Hemorrhage: A Rare Case Serial
Background: Nontraumatic spontaneous bilateral intracerebral bleeding is infrequent, with only 30-40 cases reported worldwide. Hypertension is the leading cause due to the formatio...
Small primary intracerebral hemorrhage. Clinical presentation of 28 cases.
Small primary intracerebral hemorrhage. Clinical presentation of 28 cases.
Although there have been sporadic reports of patients with small intracerebral hemorrhages presenting with discrete clinical features, the clinical and distributional characteristi...
Intracerebral Hemorrhage
Intracerebral Hemorrhage
Intracerebral hemorrhage can be classified as either secondary (due to trauma, vascular malformations, aneurysms, tumors, or hemorrhagic transformation of ischemic stroke) or prima...
The expression of Galectins-8 and its effect on neuroinflammation after intracerebral hemorrhage
The expression of Galectins-8 and its effect on neuroinflammation after intracerebral hemorrhage
Abstract At present, there is no effective treatment for secondary brain injury caused by spontaneous intracerebral hemorrhage (ICH). This study aims to explore new therape...
SUMMARY
SUMMARY
SUMMARYThe purpose of the present monograph is to give an account of the distribution of fibrinolytic components in the organism, with special reference to the tissue activator of ...

Back to Top